Absolute Eosinophil Count (AEC) Calculator

Calculate absolute eosinophil count from WBC and differential. Classify eosinophilia severity, review differentials, and get workup guidance by clinical context.

⚠️ Medical Disclaimer: This calculator is for healthcare professionals. Eosinophil interpretation requires clinical correlation. Severe eosinophilia (>5000/µL) warrants urgent evaluation for end-organ damage.
× 10³/µL (K/µL)
%
Quick Examples:
Absolute Eosinophil Count (AEC)
375.00 cells/µL
WBC 7.5 K/µL × 5% = 375.00 cells/µL
Classification
Normal
Within normal reference range (100–500 cells/µL).

Eosinophilia Classification

AEC (cells/µL)ClassificationKey ConsiderationsStatus
<100EosinopeniaAcute stress, steroids, Cushing
100–500NormalNo workup needed
500–1,500Mild eosinophiliaAtopy, drugs, mild parasites
1,500–5,000Moderate eosinophiliaParasites, vasculitis, EoE, DRESS
>5,000Severe (hypereosinophilia)HES, CEL, organ damage risk

Workup by Clinical Context

ContextFirst-Line TestsWhen to Escalate
Allergy/AsthmaTotal IgE, allergen-specific IgE, spirometryAEC >1500 or refractory to treatment
GI SymptomsStool O&P ×3, Strongyloides IgG, celiac panelEGD/colonoscopy with biopsies for tissue eosinophils
Skin/RashSkin biopsy, drug review, tryptasePersistent or worsening rash, DRESS criteria
Travel HistoryStool O&P, Strongyloides serology, blood smear (filaria)Persistent eosinophilia or tissue migration symptoms
HematologicPeripheral smear, B12, tryptase, PDGFRA/FGFR1FIP1L1-PDGFRA fusion, bone marrow biopsy
Planning notes, formulas, and examples

About the Absolute Eosinophil Count (AEC) Calculator

The Absolute Eosinophil Count (AEC) Calculator converts white blood cell count and eosinophil differential percentage into the absolute eosinophil count — the standard measure for classifying eosinophilia and guiding workup decisions. Eosinophils are granulocytes primarily involved in parasitic defense and allergic/inflammatory responses, normally comprising 1–5% of circulating white blood cells (100–500 cells/µL).

Eosinophilia is classified by severity: mild (500–1,500/µL, typically allergic or atopic causes), moderate (1,500–5,000/µL, suggesting parasitic infection, eosinophilic GI disease, or vasculitis), and severe/hypereosinophilia (>5,000/µL, requiring urgent evaluation for hypereosinophilic syndrome, eosinophilic leukemia, or end-organ damage). Even mild eosinophilia in the right clinical context (travel history, new medications, GI symptoms) warrants targeted investigation.

It shows AEC computation from WBC + differential or direct input, severity classification using standard cutoffs, common differential diagnoses stratified by AEC level, and context-specific workup recommendations for allergy, GI, skin, travel, and hematologic presentations. Pediatric and neonatal reference ranges are included, as normal values differ from adults.

When This Page Helps

The relative eosinophil percentage can be misleading — a 5% eosinophil count with a WBC of 3.0 K/µL (AEC = 150, normal) is very different from 5% with a WBC of 20.0 K/µL (AEC = 1,000, moderate eosinophilia). The absolute count is essential for accurate classification and determines whether further workup is needed.

How to Use the Inputs

  1. Choose input mode: WBC + eosinophil percentage OR direct absolute count.
  2. Enter the WBC count (in K/µL or ×10³/µL) and eosinophil percentage from the CBC differential.
  3. Select the patient age group for age-appropriate reference ranges.
  4. Select the clinical context to receive tailored workup suggestions.
  5. Review the AEC classification, differential diagnoses, and recommended investigations.
Formula used
Absolute Eosinophil Count (AEC) = WBC (×10³/µL) × Eosinophil% / 100 × 1000 Result in cells/µL Normal range: 100–500 cells/µL (adults) Mild eosinophilia: 500–1,500 cells/µL Moderate eosinophilia: 1,500–5,000 cells/µL Severe eosinophilia: >5,000 cells/µL Neonatal normal: up to 1,000 cells/µL Pediatric normal: up to 700 cells/µL

Example Calculation

Result: AEC: 960 cells/µL — Mild Eosinophilia

WBC 8.0 K/µL × 12% = 0.96 K/µL = 960 cells/µL. This falls in the mild eosinophilia range (500–1,500). In the absence of travel history, common causes include allergic rhinitis, asthma, eczema, or drug hypersensitivity. First-line workup: medication review, total IgE, allergen-specific testing if clinically indicated.

Tips & Best Practices

  • Always use the absolute count, not the percentage — a high percentage with a low WBC may be within normal limits.
  • Corticosteroids rapidly decrease eosinophil counts by promoting eosinophil apoptosis — check before starting steroids.
  • Strongyloides serologic testing is critical before immunosuppression — hyperinfection syndrome can be fatal.
  • Drug reactions (especially antibiotics, NSAIDs, anticonvulsants) are among the most common causes of eosinophilia.
  • Eosinophilia with AEC >1,500 persisting >6 months with end-organ damage defines Hypereosinophilic Syndrome (HES).
  • Always obtain stool ova & parasites (O&P ×3 specimens) and Strongyloides serology for unexplained moderate-severe eosinophilia.

Systematic Approach to Eosinophilia

Step 1: Confirm with absolute count (not percentage). Step 2: Review medications — drug reactions are the most common remediable cause. Step 3: Travel and exposure history — helminthic infections are the most common cause worldwide. Step 4: Assess for allergic/atopic disease (IgE, skin testing). Step 5: Check stool O&P (×3), Strongyloides serology, Toxocara serology. Step 6: For persistent moderate-severe eosinophilia, evaluate for end-organ damage (echo, troponin, liver function, chest imaging). Step 7: If no etiology found, consider hematologic workup (peripheral smear, B12, tryptase, PDGFRA/FGFR1, bone marrow).

Eosinophilia in Special Populations

Pregnancy: mild eosinophilia is common and usually benign. HIV: eosinophilia may indicate drug reaction, adrenal insufficiency, or co-infection (Strongyloides, Toxocara). Transplant recipients: Strongyloides screening is mandatory before immunosuppression. Neonates: higher reference range (up to 1,000/µL) — consider congenital infections for persistent elevation.

Therapeutic Targeting of Eosinophils

Modern biologics targeting the eosinophilic pathway have transformed treatment: mepolizumab and reslizumab (anti-IL-5), benralizumab (anti-IL-5Rα), and dupilumab (anti-IL-4Rα) are approved for severe eosinophilic asthma, EGPA, and atopic dermatitis. These therapies dramatically reduce AEC (often to <100/µL) and improve clinical outcomes. They represent a paradigm shift from broad immunosuppression (corticosteroids) to targeted eosinophil depletion.

Sources & Methodology

Last updated:

Methodology

This worksheet converts absolute and relative eosinophil counts into the standard reference context and compares the result with the usual range bands. It is a lab-interpretation aid, not a diagnosis.

Sources

  • Eosinophil count (MedlinePlus) — Reference range and interpretation context for eosinophil counts.
  • Eosinophilia (Merck Manual) — Clinical context for elevated eosinophil counts.

Frequently Asked Questions

  • The most common causes vary by geography. In developed countries: allergic diseases (asthma, allergic rhinitis, eczema, food allergies), drug reactions, and eosinophilic GI diseases are most common for mild eosinophilia. For moderate eosinophilia: parasitic infections (especially tissue-invasive helminths), vasculitis (EGPA/Churg-Strauss), and adrenal insufficiency. For severe: hypereosinophilic syndrome, eosinophilic leukemia, and parasitic migration. Globally, helminthic infections are the most common cause overall.